全球药物洗脱球囊市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测

全球药物洗脱球囊市场需求预计将从 2023 年的 654.03 万美元达到 2032 年近 1332.69 万美元的市场规模，2024 - 2032 年研究期间CAGR为 8.23%。

药物洗脱球囊（DEB）是一种用于介入性心臟病学和血管外科的医疗器材。它旨在透过结合球囊血管成形术的优点和药物输送功能来治疗狭窄或阻塞的动脉。该装置由涂有抗再狭窄药物（通常是抗增殖剂）的球囊组成。

市场动态

在多种因素的推动下，药物洗脱球囊 (DEB) 市场正在经历显着成长。全球冠状动脉疾病和周边动脉疾病盛行率不断上升是主要驱动因素，从而产生了对微创治疗的需求。 DEB 旨在预防球囊血管成形术后再狭窄，为解决动脉介入的常见问题提供了一种有针对性的方法。技术进步对于市场扩张至关重要，涂层技术、药物配方和球囊设计的不断创新提高了 DEB 的功效和安全性。 DEB 相对于其他治疗方案（例如药物洗脱支架）的偏好有助于其采用，提供药物输送而无需留下永久植入物的优势。医疗保健专业人员越来越认识到药物洗脱球囊 (DEB) 的优势，加上良好的临床结果，正在促进这些设备在动脉介入治疗中的接受度不断提高。监管部门的批准和有利的报销政策也有助于提高 DEB 在临床实践中的可及性和采用。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对全球药物洗脱球囊市场的各个细分市场进行了包容性评估。药物洗脱球囊产业的成长和趋势为本研究提供了整体方法。

市场区隔

药物洗脱球囊市场报告的这一部分提供了有关国家和区域级别细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人口统计数据以及即将到来的机会。

按产品分类

• 冠冕
• 週边
• 其他的

依技术

• 帕科卡斯
• 自由太平洋
• 运输公司
• 耐杜拉涂层
• 其他的

按最终用户

• 医院及门诊手术中心
• 导管实验室
• 其他的

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲药物洗脱球囊市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。药物洗脱球囊市场的主要参与者包括拜耳公司、美敦力、B. Braun Melsungen AG、Cook Medical, Inc.、波士顿科学公司、Becton、Dickson and Company、EuroCor、Terumo Corporation、Koninklijke Philips NV。竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

• 报告说明
  • 客观的
  • 目标受众
  • 独特的销售主张 (USP) 和产品
• 研究范围
• 研究方法论
  • 市场研究过程
  • 市场研究方法论

第 2 章：执行摘要

• 市集亮点
• 全球市场概况

第 3 章：药物洗脱球 - 产业分析

• 简介 - 市场动态
• 市场驱动因素
• 市场限制
• 机会
• 产业动态
• 波特五力分析
• 市场吸引力分析
  • 按产品分類的市场吸引力分析
  • 按技术分類的市场吸引力分析
  • 最终用户的市场吸引力分析
  • 市场吸引力分析：按地区

第 4 章：价值链分析

• 价值链分析
• 原料分析
  • 原料清单
  • 原料厂商清单
  • 主要原物料价格走势
• 潜在买家名单
• 行销管道
  • 直效行销
  • 间接行销
  • 行销通路发展趋势

第 5 章：全球药物洗脱球囊市场分析：依产品分类

• 按产品概述
• 历史和预测数据
• 按产品分析
• 冠冕
• 週边
• 其他的

第 6 章：全球药物洗脱球囊市场分析：依技术分类

• 依技术概述
• 历史和预测数据
• 依技术分析
• 帕科卡斯
• 自由派克
• 运输公司
• 耐杜拉外套
• 其他的

第 7 章：全球药物洗脱球囊市场分析：依最终使用者分类

• 最终用户概述
• 历史和预测数据
• 最终用户分析
• 医院及门诊手术中心
• 导管实验室
• 其他的

第 8 章：全球药物洗脱球囊市场分析：依地理位置

• 区域展望
• 介绍
• 北美销售分析
  • 概览、历史与预测资料销售分析
  • 北美按细分市场销售分析
  • 北美按国家销售分析
  • 美国销售分析
  • 加拿大销售分析
  • 墨西哥销售分析
• 欧洲销售分析
  • 概览、历史与预测资料销售分析
  • 欧洲按细分市场销售分析
  • 欧洲按国家销售分析
  • 英国销售分析
  • 法国销售分析
  • 德国销售分析
  • 义大利销售分析
  • 俄罗斯销售分析
  • 欧洲其他地区销售分析
• 亚太地区销售分析
  • 概览、历史与预测资料销售分析
  • 亚太地区按细分市场销售分析
  • 亚太地区国家/地区销售分析
  • 中国销售分析
  • 印度销售分析
  • 日本销售分析
  • 韩国销售分析
  • 澳洲销售分析
  • 东南亚销售分析
  • 亚太地区其他地区销售分析
• 拉丁美洲销售分析
  • 概览、历史与预测资料销售分析
  • 拉丁美洲按细分市场销售分析
  • 拉丁美洲按国家销售分析
  • 巴西销售分析
  • 阿根廷销售分析
  • 秘鲁销售分析
  • 智利销售分析
  • 拉丁美洲其他地区销售分析
• 中东和非洲销售分析
  • 概览、历史与预测资料销售分析
  • 中东和非洲按细分市场销售分析
  • 中东和非洲国家销售分析
  • 沙乌地阿拉伯销售分析
  • 阿联酋销售分析
  • 以色列销售分析
  • 南非销售分析
  • 中东其他地区和非洲销售分析

第 9 章：药物洗脱球囊公司的竞争格局

• 药物洗脱球市场竞争
• 伙伴关係/协作/协议
• 併购
• 新产品发布
• 其他发展

第 10 章：公司简介

• 公司股份分析
• 市场集中度
• Bayer AG
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Medtronic
• 公司简介
• 公司收入
• 产品
• 最近的发展
• B. Braun Melsungen AG
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Cook Medical Inc.
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Boston Scientific Corporation
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Becton
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Dickson and Company
• 公司简介
• 公司收入
• 产品
• 最近的发展
• EuroCor
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Terumo Corporation
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Koninklijke Philips NV
• 公司简介
• 公司收入
• 产品
• 最近的发展

注意 - 在公司概况中，财务详细资讯和近期发展视情况而定，或者如果是私人公司，则可能不包括在内

The global demand for Drug Eluting Balloon Market is presumed to reach the market size of nearly USD 1332.69 MN by 2032 from USD 654.03 MN in 2023 with a CAGR of 8.23% under the study period 2024 - 2032.

A drug eluting balloon (DEB) is a medical device used in interventional cardiology and vascular surgery. It is designed to treat narrowed or blocked arteries by combining the benefits of balloon angioplasty with drug-delivery capabilities. The device consists of a balloon coated with an anti-restenotic drug, typically an antiproliferative agent.

MARKET DYNAMICS

The Drug eluting balloon (DEB) market is witnessing a significant growth driven by various factors. The escalating prevalence of coronary artery disease and peripheral arterial disease globally is a primary driver, creating a demand for minimally invasive treatments. DEBs, designed to prevent restenosis after balloon angioplasty, offer a targeted approach to address a common issue in arterial interventions. Technological advancements are pivotal in market expansion, with ongoing innovations in coating technologies, drug formulations, and balloon designs enhancing the efficacy and safety of DEBs. The preference for DEBs over other treatment options, such as drug-eluting stents, contributes to their adoption, providing the advantage of drug delivery without leaving a permanent implant. The growing recognition among healthcare professionals regarding the advantages of Drug-Eluting Balloons (DEBs), coupled with favorable clinical outcomes, is fostering increased acceptance of these devices in arterial interventions. Regulatory approvals and favorable reimbursement policies also play a role enhancing the accessibility and adoption of DEBs in clinical practice.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of drug eluting balloon. The growth and trends of drug eluting balloon industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the drug eluting balloon market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

• Coronaty
• Peripheral
• Others

By Technology

• Paccocath
• Freepac
• Transpax
• Enduracoat
• Others

By End-User

• Hospitals And Ambulatory Surgery Centers
• Cath Labs
• Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Drug Eluting Balloon market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Drug Eluting Balloon market include Bayer AG, Medtronic, B. Braun Melsungen AG, Cook Medical, Inc., Boston Scientific Corporation, Becton, Dickson and Company, EuroCor, Terumo Corporation, Koninklijke Philips N.V. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . DRUG ELUTING BALLOON - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product
  • 3.7.2 Market Attractiveness Analysis By Technology
  • 3.7.3 Market Attractiveness Analysis By End-user
  • 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL DRUG ELUTING BALLOON MARKET ANALYSIS BY PRODUCT

• 5.1 Overview by Product
• 5.2 Historical and Forecast Data
• 5.3 Analysis by Product
• 5.4 Coronaty Historic and Forecast Sales by Regions
• 5.5 Peripheral Historic and Forecast Sales by Regions
• 5.6 Others Historic and Forecast Sales by Regions

6 . GLOBAL DRUG ELUTING BALLOON MARKET ANALYSIS BY TECHNOLOGY

• 6.1 Overview by Technology
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Technology
• 6.4 Paccocath Historic and Forecast Sales by Regions
• 6.5 FreePac Historic and Forecast Sales by Regions
• 6.6 TransPax Historic and Forecast Sales by Regions
• 6.7 EnduraCoat Historic and Forecast Sales by Regions
• 6.8 Others Historic and Forecast Sales by Regions

7 . GLOBAL DRUG ELUTING BALLOON MARKET ANALYSIS BY END-USER

• 7.1 Overview by End-user
• 7.2 Historical and Forecast Data
• 7.3 Analysis by End-user
• 7.4 Hospitals and Ambulatory Surgery Centers Historic and Forecast Sales by Regions
• 7.5 Cath Labs Historic and Forecast Sales by Regions
• 7.6 Others Historic and Forecast Sales by Regions

8 . GLOBAL DRUG ELUTING BALLOON MARKET ANALYSIS BY GEOGRAPHY

• 8.1. Regional Outlook
• 8.2. Introduction
• 8.3. North America Sales Analysis
  • 8.3.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.3.2. North America By Segment Sales Analysis
  • 8.3.3. North America By Country Sales Analysis
  • 8.3.4. United State Sales Analysis
  • 8.3.5. Canada Sales Analysis
  • 8.3.6. Mexico Sales Analysis
• 8.4. Europe Sales Analysis
  • 8.4.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.4.2. Europe by Segment Sales Analysis
  • 8.4.3. Europe by Country Sales Analysis
  • 8.4.4. United Kingdom Sales Analysis
  • 8.4.5. France Sales Analysis
  • 8.4.6. Germany Sales Analysis
  • 8.4.7. Italy Sales Analysis
  • 8.4.8. Russia Sales Analysis
  • 8.4.9. Rest Of Europe Sales Analysis
• 8.5. Asia Pacific Sales Analysis
  • 8.5.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.5.2. Asia Pacific by Segment Sales Analysis
  • 8.5.3. Asia Pacific by Country Sales Analysis
  • 8.5.4. China Sales Analysis
  • 8.5.5. India Sales Analysis
  • 8.5.6. Japan Sales Analysis
  • 8.5.7. South Korea Sales Analysis
  • 8.5.8. Australia Sales Analysis
  • 8.5.9. South East Asia Sales Analysis
  • 8.5.10. Rest Of Asia Pacific Sales Analysis
• 8.6. Latin America Sales Analysis
  • 8.6.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.6.2. Latin America by Segment Sales Analysis
  • 8.6.3. Latin America by Country Sales Analysis
  • 8.6.4. Brazil Sales Analysis
  • 8.6.5. Argentina Sales Analysis
  • 8.6.6. Peru Sales Analysis
  • 8.6.7. Chile Sales Analysis
  • 8.6.8. Rest of Latin America Sales Analysis
• 8.7. Middle East & Africa Sales Analysis
  • 8.7.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.7.2. Middle East & Africa by Segment Sales Analysis
  • 8.7.3. Middle East & Africa by Country Sales Analysis
  • 8.7.4. Saudi Arabia Sales Analysis
  • 8.7.5. UAE Sales Analysis
  • 8.7.6. Israel Sales Analysis
  • 8.7.7. South Africa Sales Analysis
  • 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE DRUG ELUTING BALLOON COMPANIES

• 9.1. Drug Eluting Balloon Market Competition
• 9.2. Partnership/Collaboration/Agreement
• 9.3. Merger And Acquisitions
• 9.4. New Product Launch
• 9.5. Other Developments

10 . COMPANY PROFILES OF DRUG ELUTING BALLOON INDUSTRY

• 10.1. Company Share Analysis
• 10.2. Market Concentration Rate
• 10.3. Bayer AG
  • 10.3.1. Company Overview
  • 10.3.2. Company Revenue
  • 10.3.3. Products
  • 10.3.4. Recent Developments
• 10.4. Medtronic
  • 10.4.1. Company Overview
  • 10.4.2. Company Revenue
  • 10.4.3. Products
  • 10.4.4. Recent Developments
• 10.5. B. Braun Melsungen AG
  • 10.5.1. Company Overview
  • 10.5.2. Company Revenue
  • 10.5.3. Products
  • 10.5.4. Recent Developments
• 10.6. Cook Medical Inc.
  • 10.6.1. Company Overview
  • 10.6.2. Company Revenue
  • 10.6.3. Products
  • 10.6.4. Recent Developments
• 10.7. Boston Scientific Corporation
  • 10.7.1. Company Overview
  • 10.7.2. Company Revenue
  • 10.7.3. Products
  • 10.7.4. Recent Developments
• 10.8. Becton
  • 10.8.1. Company Overview
  • 10.8.2. Company Revenue
  • 10.8.3. Products
  • 10.8.4. Recent Developments
• 10.9. Dickson and Company
  • 10.9.1. Company Overview
  • 10.9.2. Company Revenue
  • 10.9.3. Products
  • 10.9.4. Recent Developments
• 10.10. EuroCor
  • 10.10.1. Company Overview
  • 10.10.2. Company Revenue
  • 10.10.3. Products
  • 10.10.4. Recent Developments
• 10.11. Terumo Corporation
  • 10.11.1. Company Overview
  • 10.11.2. Company Revenue
  • 10.11.3. Products
  • 10.11.4. Recent Developments
• 10.12. Koninklijke Philips N.V.
  • 10.12.1. Company Overview
  • 10.12.2. Company Revenue
  • 10.12.3. Products
  • 10.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers : Impact Analysis
• Restraints : Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• List of Potential Buyers
• Analysis by Product (USD MN)
• Coronaty Market Sales by Geography (USD MN)
• Peripheral Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Analysis Market by Technology (USD MN)
• Paccocath Market Sales by Geography (USD MN)
• FreePac Market Sales by Geography (USD MN)
• TransPax Market Sales by Geography (USD MN)
• EnduraCoat Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Analysis by End-user (USD MN)
• Hospitals and Ambulatory Surgery Centers Market Sales by Geography (USD MN)
• Cath Labs Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Drug Eluting Balloon Market Sales by Geography (USD MN)
• North America Market Analysis (USD MN)
• United State Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate by Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• South East Asia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Drug Eluting Balloon Report
• Market Research Process
• Market Research Methodology
• Global Drug Eluting Balloon Market Size, by Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis by Product
• Market Attractiveness Analysis by Technology
• Market Attractiveness Analysis by End-user
• Market Attractiveness Analysis by Region
• Value Chain Analysis
• Global Market Analysis by Product (USD MN)
• Coronaty Market Sales by Geography (USD MN)
• Peripheral Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Market Analysis by Technology (USD MN)
• Paccocath Market Sales by Geography (USD MN)
• FreePac Market Sales by Geography (USD MN)
• TransPax Market Sales by Geography (USD MN)
• EnduraCoat Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Market Analysis by End-user (USD MN)
• Hospitals and Ambulatory Surgery Centers Market Sales by Geography (USD MN)
• Cath Labs Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Market Sales (USD MN)
• North America Market Sales (USD MN)
• Europe Market Sales (USD MN)
• Asia Pacific Market Sales (USD MN)
• Latin America Market Sales (USD MN)
• Middle East & Africa Market Sales (USD MN)
• Recent Development in Industry
• Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.